QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: mol.104.001743v1 66/5/1201    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Witchel, H. J. Articles by Mitcheson, J. S. Search for Related Content PubMed PubMed Citation Articles by Witchel, H. J. Articles by Mitcheson, J. S.

The Low-Potency, Voltage-Dependent HERG Blocker Propafenone—Molecular Determinants and Drug Trapping

Cardiovascular Research Laboratories and Department of Physiology, (H.J.W., J.T.M., J.C.H.) and Molecular Recognition Centre, Department of Biochemistry (C.E.D., R.B.S.), School of Medical Sciences, University of Bristol, Bristol, United Kingdom; and Department of Cell Physiology & Pharmacology, Medical Sciences Building, Leicester University, Leicester, United Kingdom (M.P., J.S.M.)

The molecular determinants of high-affinity human ether-a-go-go-related gene (HERG) potassium channel blockade by methanesulfonanilides include two aromatic residues (Phe656 and Tyr652) on the inner helices (S6) and residues on the pore helices that face into the inner cavity, but determinants for lower-affinity HERG blockers may be different. In this study, alanine-substituted HERG channel mutants of inner cavity residues were expressed in Xenopus laevis oocytes and were used to characterize the HERG channel binding site of the antiarrhythmic propafenone. Propafenone's blockade of HERG was strongly dependent on residue Phe656 but was insensitive or weakly sensitive to mutation of Tyr652, Thr623, Ser624, Val625, Gly648, or Val659 and did not require functional inactivation. Homology models of HERG based on KcsA and MthK crystal structures, representing the closed and open forms of the channel, respectively, suggest propafenone is trapped in the inner cavity and is unable to interact exclusively with Phe656 in the closed state (whereas exclusive interactions between propafenone and Phe656 are found in the open-channel model). These findings are supported by very slow recovery of wild-type HERG channels from block at -120 mV, but extremely rapid recovery of D540K channels that reopen at this potential. The experiments and modeling suggest that the open-state propafenone binding-site may be formed by the Phe656 residues alone. The binding site for propafenone (which may involve -stacking interactions with two or more Phe656 side-chains) is either perturbed or becomes less accessible because of closed-channel gating. This provides further evidence for the existence of gating-induced changes in the spatial location of Phe656 side chains.

Address correspondence to: Harry J. Witchel, Cardiovascular Research Laboratories and Department of Physiology, School of Medical Sciences, University of Bristol, Bristol, BS8 1TD, UK. E-mail: harry.witchel{at}bristol.ac.uk

This article has been cited by other articles:

				K. Kamiya, R. Niwa, J. S. Mitcheson, and M. C. Sanguinetti Molecular Determinants of hERG Channel Block Mol. Pharmacol., May 1, 2006; 69(5): 1709 - 1716. [Abstract] [Full Text] [PDF]

				S. L. Cockerill and J. S. Mitcheson Direct Block of Human Ether-a-go-go-Related Gene Potassium Channels by Caffeine J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 860 - 868. [Abstract] [Full Text] [PDF]

				G. A. Gintant, Z. Su, R. L. Martin, and B. F. Cox Utility of hERG Assays as Surrogate Markers of Delayed Cardiac Repolarization and QT Safety Toxicol Pathol, January 1, 2006; 34(1): 81 - 90. [Abstract] [Full Text] [PDF]